Excellent article showing why B-OM the leader of the pack. I highlighted a statement from the article below as I was unaware Brilacidin was working in the cancer arena as well as antibiotic/anti inflammatory.

“In aggregate, the data from the Brilacidin Phase 2 study was impressive and we will consider expanding the drug to other cancer indications in the future,” said Leo Ehrlich,